- By insider

Chairman of the Board and CEO of Abbvie Inc (ABBV) Richard A Gonzalez sold 218,193 shares of ABBV on 11/21/2017 at an average price of $94.01 a share. The total sale was $20.5 million.

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. AbbVie Inc has a market cap of $151.21 billion; its shares were traded at around $94.72 with a P/E ratio of 23.05 and P/S ratio of 5.59. The dividend yield of AbbVie Inc stocks is 2.71%. AbbVie Inc had annual average EBITDA growth of 9.50% over the past five years.

• Warning! GuruFocus has detected 6 Warning Sign with ABBV. Click here to check it out.

• ABBV 15-Year Financial Data

• The intrinsic value of ABBV

• Peter Lynch Chart of ABBV

CEO Recent Trades:

• Chairman of the Board and CEO Richard A Gonzalez sold 218,193 shares of ABBV stock on 11/21/2017 at the average price of $94.01. The price of the stock has increased by 0.76% since.

Directors and Officers Recent Trades:

• EVP, R&D and CSO Michael Severino sold 25,633 shares of ABBV stock on 11/10/2017 at the average price of $94.69. The price of the stock has increased by 0.03% since.

• Chief Strategy Officer Henry O Gosebruch sold 18,300 shares of ABBV stock on 10/30/2017 at the average price of $90.55. The price of the stock has increased by 4.61% since.

For the complete insider trading history of ABBV, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 6 Warning Sign with ABBV. Click here to check it out.

• ABBV 15-Year Financial Data

• The intrinsic value of ABBV

• Peter Lynch Chart of ABBV